Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease - PubMed (original) (raw)
Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease
W Bondareff et al. Am J Pathol. 1991 Sep.
Abstract
Antibodies directed against three regions of tau have been used in a histologic study of granulovacuolar degeneration (GVD) in Alzheimer's disease (AD). Granulovascular degeneration complexes, consisting of a dense granule in a less-dense vacuole, were found in hippocampal pyramidal neurons in all patients studied. Anti-tau antibodies directed against the N-and C-termini, and the repeat region of tau, were found to immunolabel the granule of the GVD complex. Intracellular neurofibrillary tangles also were labeled by these antibodies. In particular, MAb6.423, which recognizes tau protein sequestered in paired helical filaments (PHF) in AD, but not the normal tau proteins so far described in human brain, labeled GVD granules. Contrarily, a generic tau marker (MAb7.51), which immunolabels all known isoforms of isolated and expressed tau protein, including PHF-tau, did not label the GVD granule. These findings demonstrate that the entire tau molecule is sequestered within the GVD granule, and that the tau protein found in GVD complexes is antigenically related to that found in PHFs. There is, however, a difference in the way in which the repeat region of tau is incorporated into the two structures, making the MAb7.51 epitope unavailable in the GVD complex. These findings suggest that the formation of GVD complexes in hippocampal pyramidal neurons vulnerable to neurofibrillary degeneration may represent an alternative pathway for dealing with an aberrant molecular complex, which contributes to the formation of GVD granules and neurofibrillary tangles in AD.
Similar articles
- The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP. Leroy K, et al. Acta Neuropathol. 2002 Feb;103(2):91-9. doi: 10.1007/s004010100435. Epub 2001 Nov 29. Acta Neuropathol. 2002. PMID: 11810173 - Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S, Berry RW, Binder LI. Lagalwar S, et al. Acta Neuropathol. 2007 Jan;113(1):63-73. doi: 10.1007/s00401-006-0159-4. Epub 2006 Nov 7. Acta Neuropathol. 2007. PMID: 17089132 - Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.
Yamazaki Y, Takahashi T, Hiji M, Kurashige T, Izumi Y, Yamawaki T, Matsumoto M. Yamazaki Y, et al. Neurosci Lett. 2010 Jun 21;477(2):86-90. doi: 10.1016/j.neulet.2010.04.038. Epub 2010 Apr 24. Neurosci Lett. 2010. PMID: 20420883 - Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology.
Köhler C. Köhler C. Acta Neuropathol. 2016 Sep;132(3):339-59. doi: 10.1007/s00401-016-1562-0. Epub 2016 Apr 9. Acta Neuropathol. 2016. PMID: 27062260 Review. - Neurofibrillary pathology and aluminum in Alzheimer's disease.
Shin RW, Lee VM, Trojanowski JQ. Shin RW, et al. Histol Histopathol. 1995 Oct;10(4):969-78. Histol Histopathol. 1995. PMID: 8574016 Review.
Cited by
- Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients--a quantitative study.
Xu M, Shibayama H, Kobayashi H, Yamada K, Ishihara R, Zhao P, Takeuchi T, Yoshida K, Inagaki T, Nokura K. Xu M, et al. Acta Neuropathol. 1992;85(1):1-9. doi: 10.1007/BF00304627. Acta Neuropathol. 1992. PMID: 1285490 - Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM. Mukaetova-Ladinska EB, et al. Am J Pathol. 1993 Aug;143(2):565-78. Am J Pathol. 1993. PMID: 8342603 Free PMC article. - Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles.
Hunter S, Minett T, Polvikoski T, Mukaetova-Ladinska E, Brayne C; Cambridge City over-75s Cohort Collaboration. Hunter S, et al. Alzheimers Res Ther. 2015 Aug 28;7(1):57. doi: 10.1186/s13195-015-0141-2. Alzheimers Res Ther. 2015. PMID: 26315613 Free PMC article. - Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: localization of two amino terminal tau epitopes in GVB.
Dickson DW, Liu WK, Kress Y, Ku J, DeJesus O, Yen SH. Dickson DW, et al. Acta Neuropathol. 1993;85(5):463-70. doi: 10.1007/BF00230483. Acta Neuropathol. 1993. PMID: 7684177 - Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles.
Funk KE, Mrak RE, Kuret J. Funk KE, et al. Neuropathol Appl Neurobiol. 2011 Apr;37(3):295-306. doi: 10.1111/j.1365-2990.2010.01135.x. Neuropathol Appl Neurobiol. 2011. PMID: 20946470 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1986 Jun;83(11):4040-3 - PubMed
- Proc Natl Acad Sci U S A. 1986 Jun;83(11):4044-8 - PubMed
- Brain. 1961 Dec;84:662-79 - PubMed
- Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5842-6 - PubMed
- Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5837-41 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical